Northland Securities reissued their market perform rating on shares of XOS (NASDAQ:XOS – Free Report) in a research report sent to investors on Monday morning, Marketbeat Ratings reports. The firm currently has a $5.00 target price on the stock, down from their prior target price of $9.00.
XOS has been the subject of a number of other research reports. Northland Capmk upgraded XOS to a “strong-buy” rating in a report on Wednesday, October 2nd. DA Davidson cut shares of XOS from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $17.00 to $9.00 in a research report on Friday, August 16th. Wedbush reduced their target price on shares of XOS from $15.00 to $12.00 and set an “outperform” rating on the stock in a research report on Thursday, August 15th. Roth Mkm started coverage on XOS in a report on Wednesday, October 23rd. They issued a “buy” rating and a $15.00 price target for the company. Finally, Roth Capital upgraded XOS to a “strong-buy” rating in a report on Wednesday, October 23rd. Three equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $10.25.
View Our Latest Research Report on XOS
XOS Trading Down 4.8 %
XOS Company Profile
Xos, Inc designs, manufactures, and sells battery-electric commercial vehicles. The company provides class 5-6 medium duty rolling chassis, such as commercial stepvans and armored trucks; class 7-8 heavy duty chassis; and Xos product development. It offers Xos provides mix-use powertrain solutions for off-highway, industrial and other commercial equipment, and specialty vehicles, such as school buses, medical and dental clinics, blood donation vehicles, and mobile command vehicles.
Featured Articles
- Five stocks we like better than XOS
- What is Forex and How Does it Work?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Investing in the High PE Growth Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Do S&P 500 Stocks Tell Investors About the Market?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for XOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOS and related companies with MarketBeat.com's FREE daily email newsletter.